Testosterone measurements in early infancy
- 1Bone & Endocrine Research Group, Department of Child Health, Royal Hospital For Sick Children, Yorkhill, Glasgow G3 8SJ, Scotland, UK
- 2Department of Clinical Biochemistry, Glasgow Royal Infirmary, Glasgow G4 0SF
- Correspondence to:
Dr Wallace
Department of Clinical Biochemistry, Glasgow Royal Infirmary, Glasgow G4 0SF, Scotland, UK; MWallacegri-biochem.org.uk
- Accepted 5 March 2004
Abstract
Circulating testosterone concentrations in infants measured by a direct chemiluminescent immunoassay (Bayer ADVIA Centaur) were compared with those measured by a traditional radioimmunoassay using solvent extraction. The results confirm that neonatal circulating testosterone concentrations are method dependent, and each laboratory should establish method related reference ranges especially if using a direct commercial immunoassay. The results indicate that the Bayer ADVIA Centaur procedure can be used reliably in neonates. Expected values for male and female infants < 10 days old were 2.5–11.1 (n = 36) and 1.7–5.6 (n = 36) nmol/l respectively. For older neonates (10–50 days) the ranges were 0.2–17.2 (n = 42) and 0.1–1.5 (n = 7) nmol/l respectively.
